On June 14, five weeks after I had completed 20 proton radiation treatments, I underwent a CT scan with contrast dye (a radiopaque agent that contains iodine injected via an I-V). The purpose of the scan was to enable my Penn-Lancaster General medical team to assess the combined effectiveness of radiation, ongoing immunotherapy, and surgery, which in February had removed a malignant melanoma tumor hosted by my left parotid gland.

Here is the radiologists’ summary of this week’s scan: “Status post proton radiation to LEFT parotid metastases. Indistinct residual soft tissue within the LEFT parotid gland and adjacent sternocleidomastoid muscle may represent scarring/post treatment change and will serve as baseline for future comparison studies. No new or enlarging soft tissue mass or lymphadenopathy in the neck.”

Yesterday I met with radiation oncologist Sriram Venigalla, who interpreted the results of the scan. The “course intent” of the radiation treatments, as noted on each follow-up report, had been “curative.” Dr. Venigalla said the “course intent” has been achieved – I am currently cancer-free.

My response is deep gratitude for this result, tinged with great empathy for other cancer patients whose results have not been so positive. I think of many beloved family members, dear friends, close high school and college classmates, and esteemed colleagues who have succumbed to cancer. I especially feel for those who currently endure rounds of chemotherapy and face uncertain futures.

Dr. Venigalla called my new status “maintenance” as I will continue with immunotherapy every six weeks until the end of the year. Then another scan will follow. Afterward, assuming a favorable outcome, I will be in “surveillance mode” for five years, periodically checking for lesions or lumps which could indicate a recurrence of melanoma.

Again, I want to thank the Penn-LGH medical team members who have given me the benefit of their expertise; they have always delivered their counsel and treatments with an attitude of care and with hope for an optimal outcome. Also meriting praise are the scientists behind the development of recent amazing protocols for cancer. Dr. Venigalla noted, for example, that my particular proton radiation treatment – while delivered at the Barshinger Cancer Institute in Lancaster – was designed by his colleagues at Penn Medicine in Philadelphia.

Finally, I am grateful for you – for everyone who has prayed for me, expressed interest and concern, and cheered me on after each CaringBridge journal entry. Thanks be to God for all that is good. Onward!